Keun‐Wook Lee

15.7k total citations · 2 hit papers
265 papers, 7.3k citations indexed

About

Keun‐Wook Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Keun‐Wook Lee has authored 265 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Oncology, 109 papers in Pulmonary and Respiratory Medicine and 62 papers in Surgery. Recurrent topics in Keun‐Wook Lee's work include Gastric Cancer Management and Outcomes (75 papers), Colorectal Cancer Treatments and Studies (61 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Keun‐Wook Lee is often cited by papers focused on Gastric Cancer Management and Outcomes (75 papers), Colorectal Cancer Treatments and Studies (61 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Keun‐Wook Lee collaborates with scholars based in South Korea, United States and Japan. Keun‐Wook Lee's co-authors include Jee Hyun Kim, Yung‐Jue Bang, Jin Won Kim, Soo‐Mee Bang, Yeul Hong Kim, Y. Choi, Hyun Cheol Chung, Jong Seok Lee, Jeong‐Ok Lee and Kyung Hee Lee and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Keun‐Wook Lee

254 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

2012 1.2k citations Yung‐Jue Bang, Hyun Cheol Chung et al. profile →
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

2017 429 citations Keun‐Wook Lee et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Keun‐Wook Lee	4.0k	3.3k	2.0k	1.3k	1.0k	265	7.3k
Didier Cupissol	4.9k 1.2×	4.4k 1.3×	2.5k 1.3×	1.6k 1.2×	805 0.8×	160	8.9k
Yelena Y. Janjigian	5.0k 1.2×	5.0k 1.5×	2.4k 1.2×	1.9k 1.5×	1.1k 1.1×	253	8.5k
Vladimir Moiseyenko	5.6k 1.4×	4.1k 1.3×	1.8k 0.9×	1.0k 0.8×	1.1k 1.1×	142	8.1k
Yoshito Komatsu	4.1k 1.0×	3.5k 1.1×	2.2k 1.1×	984 0.8×	1.1k 1.1×	319	6.6k
Tae Won Kim	5.1k 1.3×	2.5k 0.8×	1.7k 0.8×	1.3k 1.0×	607 0.6×	296	7.5k
Min‐Hee Ryu	3.7k 0.9×	4.5k 1.4×	2.4k 1.2×	847 0.7×	2.2k 2.2×	327	7.6k
Giuseppe Aprile	5.6k 1.4×	5.0k 1.5×	2.5k 1.3×	2.0k 1.6×	1.3k 1.3×	232	9.8k
Е. С. Куликов	3.0k 0.8×	3.4k 1.0×	1.5k 0.8×	1.1k 0.9×	1.1k 1.1×	64	5.6k
Joan Maurel	6.9k 1.7×	3.9k 1.2×	2.5k 1.3×	1.2k 1.0×	1.1k 1.1×	221	9.4k
Naureen Starling	3.8k 0.9×	2.7k 0.8×	1.6k 0.8×	1.2k 0.9×	763 0.8×	171	6.2k

Countries citing papers authored by Keun‐Wook Lee

Since Specialization

Citations

This map shows the geographic impact of Keun‐Wook Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keun‐Wook Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keun‐Wook Lee more than expected).

Fields of papers citing papers by Keun‐Wook Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keun‐Wook Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keun‐Wook Lee. The network helps show where Keun‐Wook Lee may publish in the future.

Co-authorship network of co-authors of Keun‐Wook Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Keun‐Wook Lee. A scholar is included among the top collaborators of Keun‐Wook Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keun‐Wook Lee. Keun‐Wook Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moehler, Markus, Do‐Youn Oh, Ken Kato, et al.. (2025). First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305. Advances in Therapy. 42(5). 2248–2268. 2 indexed citations

Lee, Ji Yun, Ju Hyun Lee, Min-Su Kang, et al.. (2024). Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study. Journal of Korean Medical Science. 39(22). e175–e175. 1 indexed citations

Han, Hye Sook & Keun‐Wook Lee. (2024). Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer. Journal of the Korean Gastric Cancer Association. 24(1). 4–4. 18 indexed citations

Oh, Soo Jin, Soo Kyung Nam, Keun‐Wook Lee, et al.. (2023). Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis. Cancer Research and Treatment. 56(1). 219–237. 8 indexed citations

Lim, Yoojoo, Chan‐Young Ock, Gahee Park, et al.. (2023). Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head & Neck. 45(12). 3086–3095. 5 indexed citations

Lee, Yun‐Gyoo, Eun Joo Kang, Bhumsuk Keam, et al.. (2023). Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01). Cancers. 15(2). 471–471.

Yamaguchi, Kensei, Yung‐Jue Bang, Satoru Iwasa, et al.. (2022). Trastuzumab Deruxtecan in Anti–Human Epidermal Growth Factor Receptor 2 Treatment–Naive Patients With Human Epidermal Growth Factor Receptor 2–Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial. Journal of Clinical Oncology. 41(4). 816–825. 76 indexed citations

Jung, Eun Hee, Yu Jung Kim, Beodeul Kang, et al.. (2022). Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center. JCO Oncology Practice. 18(10). e1661–e1671. 8 indexed citations

Jung, Hyun Ae, Keon Uk Park, Sang‐Hee Cho, et al.. (2022). A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17–11). Clinical Cancer Research. 28(19). 4240–4247. 18 indexed citations

10.

Kim, Yu Jung, Sang‐Yeon Suh, Yusuke Hiratsuka, et al.. (2022). Performance of clinician prediction of survival in oncology outpatients with advanced cancer. PLoS ONE. 17(4). e0267467–e0267467. 7 indexed citations

11.

Kang, Min-Su, Koung Jin Suh, Ji‐Won Kim, et al.. (2022). Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study. PLoS ONE. 17(1). e0261671–e0261671. 3 indexed citations

12.

Lee, Keun‐Wook, Eric Van Cutsem, Yung‐Jue Bang, et al.. (2022). Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. Clinical Cancer Research. 28(16). 3489–3498. 55 indexed citations

13.

Wainberg, Zev A., Peter C. Enzinger, Yoon‐Koo Kang, et al.. (2021). Randomized double-blind placebo-controlled phase 2 study of bemarituzumab combined with modified FOLFOX6 (mFOLFOX6) in first-line (1L) treatment of advanced gastric/gastroesophageal junction adenocarcinoma (FIGHT).. Journal of Clinical Oncology. 39(3_suppl). 160–160. 63 indexed citations

14.

Kang, Eun Joo, Myung‐Ju Ahn, Chan-Young Ock, et al.. (2021). Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma. Clinical Cancer Research. 27(19). 5272–5279. 39 indexed citations

15.

Kim, Se Hyun, Chan-Young Ock, Koung Jin Suh, et al.. (2018). BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression. International Journal of Molecular Sciences. 19(10). 3164–3164. 17 indexed citations

16.

Lee, Yoontaek, Sa-Hong Min, Ki Bum Park, et al.. (2018). Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis. Journal of the Korean Gastric Cancer Association. 18(1). 58–58. 11 indexed citations

17.

Ock, Chan-Young, Keun‐Wook Lee, Jin Won Kim, et al.. (2015). Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer. Clinical Cancer Research. 21(11). 2520–2529. 52 indexed citations

18.

Lee, Keun‐Wook, Sung Sook Lee, Sang-Bae Kim, et al.. (2014). Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients. Clinical Cancer Research. 21(2). 357–364. 132 indexed citations

19.

Lee, Jeong‐Ok, Ju Hyun Lee, Soyeon Ahn, et al.. (2014). Prevalence and Risk Factors for Iron Deficiency Anemia in the Korean Population: Results of the Fifth Korea National Health and Nutrition Examination Survey. Journal of Korean Medical Science. 29(2). 224–224. 53 indexed citations

20.

Lee, Keun‐Wook, Sang Gyun Kim, Hwang‐Phill Kim, et al.. (2008). Enzastaurin, a Protein Kinase Cβ Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer Cells. Cancer Research. 68(6). 1916–1926. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact